Involvement of AP-1 and Steroidogenic Factor (SF)-1 in the cAMP-Dependent Induction of Human Adrenocorticotropic Hormone Receptor (ACTHR) Promoter

Adrenocorticotropic hormone receptor (ACTHR) is expressed predominantly in the adrenal glands, and its expression is upregulated by its own ligand, ACTH, via a cAMP-dependent pathway. In the present study, we characterized the 5'-regulatory region of human ACTHR gene to elucidate the molecular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ENDOCRINE JOURNAL 2000, Vol.47(1), pp.63-75
Hauptverfasser: SARKAR, DEVANAND, KAMBE, FUKUSHI, HAYASHI, YOSHITAKA, OHMORI, SACHIKO, FUNAHASHI, HIROOMI, SEO, HISAO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 75
container_issue 1
container_start_page 63
container_title ENDOCRINE JOURNAL
container_volume 47
creator SARKAR, DEVANAND
KAMBE, FUKUSHI
HAYASHI, YOSHITAKA
OHMORI, SACHIKO
FUNAHASHI, HIROOMI
SEO, HISAO
description Adrenocorticotropic hormone receptor (ACTHR) is expressed predominantly in the adrenal glands, and its expression is upregulated by its own ligand, ACTH, via a cAMP-dependent pathway. In the present study, we characterized the 5'-regulatory region of human ACTHR gene to elucidate the molecular mechanisms underlying its adrenal-specific and ACTH/cAMP-dependent expression. The promoter region (-1017/+47 when the transcription start site is regarded as +1) and its serial 5'-deletions (-764/+47, -503/+47, -214/+47 and -561+47) were ligated into the upstream of a luciferase (luc) reporter gene. These constructs were transfected into adrenocortical Y1 cells or non-adrenal JEG3 and Cos-1 cells. In all the cell lines, the luc activity gradually increased with serial 5'-deletions and the maximum activity was conferred by -56/+47. However, the magnitude of luc activity of each deletion construct in non-adrenal cells was much less than that in Y1 cells, suggesting that the promoter functions in an adrenal-specific manner. We identified two Steroidogenic Factor (SF)-1-binding sites at -209 and -35. Electrophoretic mobility shift assay (EMSA) demonstrated that both sites bind to SF-1. Mutation of both sites significantly decreased the activity of -214/+47 promoter in Y1 cells. Transfection of SF-1-expressing plasmid into non-adrenal cells significantly increased the promoter activity, suggesting that SF-1 plays a role in the tissue-specific expression of human ACTHR gene. We identified the region, -764 to -503, that was required for the for- skolin/camp responsiveness of the promoter. This region contains one AP-1 site. EMSA revealed that the binding of AP-1 to this site increased significantly upon treatment of Y1 cells with forskolin. Mutation of the site abolished the forskolin-responsiveness. In non-adrenal cells, the forskolin-responsiveness was observed only when SF-1-expressing plasmid was cotransfected. This is the first demonstration that both AP-1 and SF-1 are required for the cAMP-dependent induction of human ACTHR gene.
doi_str_mv 10.1507/endocrj.47.63
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71141670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71141670</sourcerecordid><originalsourceid>FETCH-LOGICAL-c621t-200cfd8b12649d5c9adc1d2a91734cd9085186ff9f00ee6326f0b6d5818622003</originalsourceid><addsrcrecordid>eNpNkcFu1DAQhiMEokvhyBX5hOghiydOnPi4Wlh2pSJWbTlbXnvSZpXYqeNU4jX6xHWaLXAZW55_vvk9kyQfgS6hoOVXtMZpf1zm5ZKzV8kCWF6leZHT18mCCqjSShTiLHk3DEdKGSty9jY5A1oBZKJYJI87--DaB-zQBuJqstqnQJQ15Dqgd41xt2gbTTZKB-fJl-vNRcw3loQ7JHr1c59-wz5amKp31ow6NM5OnO3YKUtWxqN12vnQaBe86yNq63znLJIr1Ng_Q1frm-3VBdl717nY9X3yplbtgB9O53nye_P9Zr1NL3_92K1Xl6nmGYQ0o1TXpjpAxnNhCi2U0WAyJaBkuTaCVgVUvK5FTSkiZxmv6YGbooqvWSxm58nnmdt7dz_iEGTXDBrbVll04yBLgBx4OQnTWai9GwaPtex90yn_RwKV0xLkaQkyLyVnUf_pBB4PHZr_1PPUo2AzC2K20ap1tm0syqMbvY0_lvqePxNltEklpXlJQVKYrpzFUBaxKTD6D3QcgrrFv53UNPAWX3yBEGzyBnOIjBeBvlM-qtgTUJqyoQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71141670</pqid></control><display><type>article</type><title>Involvement of AP-1 and Steroidogenic Factor (SF)-1 in the cAMP-Dependent Induction of Human Adrenocorticotropic Hormone Receptor (ACTHR) Promoter</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>SARKAR, DEVANAND ; KAMBE, FUKUSHI ; HAYASHI, YOSHITAKA ; OHMORI, SACHIKO ; FUNAHASHI, HIROOMI ; SEO, HISAO</creator><creatorcontrib>SARKAR, DEVANAND ; KAMBE, FUKUSHI ; HAYASHI, YOSHITAKA ; OHMORI, SACHIKO ; FUNAHASHI, HIROOMI ; SEO, HISAO ; Department of Endocrinology and Metabolism ; Nagoya University School of Medicine ; Research Institute of Environmental Medicine ; nagoya University ; Department of Surgery II</creatorcontrib><description>Adrenocorticotropic hormone receptor (ACTHR) is expressed predominantly in the adrenal glands, and its expression is upregulated by its own ligand, ACTH, via a cAMP-dependent pathway. In the present study, we characterized the 5'-regulatory region of human ACTHR gene to elucidate the molecular mechanisms underlying its adrenal-specific and ACTH/cAMP-dependent expression. The promoter region (-1017/+47 when the transcription start site is regarded as +1) and its serial 5'-deletions (-764/+47, -503/+47, -214/+47 and -561+47) were ligated into the upstream of a luciferase (luc) reporter gene. These constructs were transfected into adrenocortical Y1 cells or non-adrenal JEG3 and Cos-1 cells. In all the cell lines, the luc activity gradually increased with serial 5'-deletions and the maximum activity was conferred by -56/+47. However, the magnitude of luc activity of each deletion construct in non-adrenal cells was much less than that in Y1 cells, suggesting that the promoter functions in an adrenal-specific manner. We identified two Steroidogenic Factor (SF)-1-binding sites at -209 and -35. Electrophoretic mobility shift assay (EMSA) demonstrated that both sites bind to SF-1. Mutation of both sites significantly decreased the activity of -214/+47 promoter in Y1 cells. Transfection of SF-1-expressing plasmid into non-adrenal cells significantly increased the promoter activity, suggesting that SF-1 plays a role in the tissue-specific expression of human ACTHR gene. We identified the region, -764 to -503, that was required for the for- skolin/camp responsiveness of the promoter. This region contains one AP-1 site. EMSA revealed that the binding of AP-1 to this site increased significantly upon treatment of Y1 cells with forskolin. Mutation of the site abolished the forskolin-responsiveness. In non-adrenal cells, the forskolin-responsiveness was observed only when SF-1-expressing plasmid was cotransfected. This is the first demonstration that both AP-1 and SF-1 are required for the cAMP-dependent induction of human ACTHR gene.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.47.63</identifier><identifier>PMID: 10811295</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>ACTH receptor ; Animals ; AP-1 ; Base Sequence - genetics ; Binding Sites ; cAMP ; Cell Line ; COS Cells ; Cyclic AMP - metabolism ; Cyclic AMP - physiology ; DNA-Binding Proteins - metabolism ; DNA-Binding Proteins - physiology ; Electrophoresis ; Fushi Tarazu Transcription Factors ; Gene Expression Regulation - physiology ; Homeodomain Proteins ; Humans ; Molecular Sequence Data ; Promoter ; Promoter Regions, Genetic ; Receptors, Corticotropin - genetics ; Receptors, Cytoplasmic and Nuclear ; SF-1 ; Steroidogenic Factor 1 ; Transcription Factor AP-1 - metabolism ; Transcription Factor AP-1 - physiology ; Transcription Factors - metabolism ; Transcription Factors - physiology</subject><ispartof>Endocrine Journal, 2000, Vol.47(1), pp.63-75</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c621t-200cfd8b12649d5c9adc1d2a91734cd9085186ff9f00ee6326f0b6d5818622003</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1876,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10811295$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SARKAR, DEVANAND</creatorcontrib><creatorcontrib>KAMBE, FUKUSHI</creatorcontrib><creatorcontrib>HAYASHI, YOSHITAKA</creatorcontrib><creatorcontrib>OHMORI, SACHIKO</creatorcontrib><creatorcontrib>FUNAHASHI, HIROOMI</creatorcontrib><creatorcontrib>SEO, HISAO</creatorcontrib><creatorcontrib>Department of Endocrinology and Metabolism</creatorcontrib><creatorcontrib>Nagoya University School of Medicine</creatorcontrib><creatorcontrib>Research Institute of Environmental Medicine</creatorcontrib><creatorcontrib>nagoya University</creatorcontrib><creatorcontrib>Department of Surgery II</creatorcontrib><title>Involvement of AP-1 and Steroidogenic Factor (SF)-1 in the cAMP-Dependent Induction of Human Adrenocorticotropic Hormone Receptor (ACTHR) Promoter</title><title>ENDOCRINE JOURNAL</title><addtitle>Endocr J</addtitle><description>Adrenocorticotropic hormone receptor (ACTHR) is expressed predominantly in the adrenal glands, and its expression is upregulated by its own ligand, ACTH, via a cAMP-dependent pathway. In the present study, we characterized the 5'-regulatory region of human ACTHR gene to elucidate the molecular mechanisms underlying its adrenal-specific and ACTH/cAMP-dependent expression. The promoter region (-1017/+47 when the transcription start site is regarded as +1) and its serial 5'-deletions (-764/+47, -503/+47, -214/+47 and -561+47) were ligated into the upstream of a luciferase (luc) reporter gene. These constructs were transfected into adrenocortical Y1 cells or non-adrenal JEG3 and Cos-1 cells. In all the cell lines, the luc activity gradually increased with serial 5'-deletions and the maximum activity was conferred by -56/+47. However, the magnitude of luc activity of each deletion construct in non-adrenal cells was much less than that in Y1 cells, suggesting that the promoter functions in an adrenal-specific manner. We identified two Steroidogenic Factor (SF)-1-binding sites at -209 and -35. Electrophoretic mobility shift assay (EMSA) demonstrated that both sites bind to SF-1. Mutation of both sites significantly decreased the activity of -214/+47 promoter in Y1 cells. Transfection of SF-1-expressing plasmid into non-adrenal cells significantly increased the promoter activity, suggesting that SF-1 plays a role in the tissue-specific expression of human ACTHR gene. We identified the region, -764 to -503, that was required for the for- skolin/camp responsiveness of the promoter. This region contains one AP-1 site. EMSA revealed that the binding of AP-1 to this site increased significantly upon treatment of Y1 cells with forskolin. Mutation of the site abolished the forskolin-responsiveness. In non-adrenal cells, the forskolin-responsiveness was observed only when SF-1-expressing plasmid was cotransfected. This is the first demonstration that both AP-1 and SF-1 are required for the cAMP-dependent induction of human ACTHR gene.</description><subject>ACTH receptor</subject><subject>Animals</subject><subject>AP-1</subject><subject>Base Sequence - genetics</subject><subject>Binding Sites</subject><subject>cAMP</subject><subject>Cell Line</subject><subject>COS Cells</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic AMP - physiology</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>DNA-Binding Proteins - physiology</subject><subject>Electrophoresis</subject><subject>Fushi Tarazu Transcription Factors</subject><subject>Gene Expression Regulation - physiology</subject><subject>Homeodomain Proteins</subject><subject>Humans</subject><subject>Molecular Sequence Data</subject><subject>Promoter</subject><subject>Promoter Regions, Genetic</subject><subject>Receptors, Corticotropin - genetics</subject><subject>Receptors, Cytoplasmic and Nuclear</subject><subject>SF-1</subject><subject>Steroidogenic Factor 1</subject><subject>Transcription Factor AP-1 - metabolism</subject><subject>Transcription Factor AP-1 - physiology</subject><subject>Transcription Factors - metabolism</subject><subject>Transcription Factors - physiology</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkcFu1DAQhiMEokvhyBX5hOghiydOnPi4Wlh2pSJWbTlbXnvSZpXYqeNU4jX6xHWaLXAZW55_vvk9kyQfgS6hoOVXtMZpf1zm5ZKzV8kCWF6leZHT18mCCqjSShTiLHk3DEdKGSty9jY5A1oBZKJYJI87--DaB-zQBuJqstqnQJQ15Dqgd41xt2gbTTZKB-fJl-vNRcw3loQ7JHr1c59-wz5amKp31ow6NM5OnO3YKUtWxqN12vnQaBe86yNq63znLJIr1Ng_Q1frm-3VBdl717nY9X3yplbtgB9O53nye_P9Zr1NL3_92K1Xl6nmGYQ0o1TXpjpAxnNhCi2U0WAyJaBkuTaCVgVUvK5FTSkiZxmv6YGbooqvWSxm58nnmdt7dz_iEGTXDBrbVll04yBLgBx4OQnTWai9GwaPtex90yn_RwKV0xLkaQkyLyVnUf_pBB4PHZr_1PPUo2AzC2K20ap1tm0syqMbvY0_lvqePxNltEklpXlJQVKYrpzFUBaxKTD6D3QcgrrFv53UNPAWX3yBEGzyBnOIjBeBvlM-qtgTUJqyoQ</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>SARKAR, DEVANAND</creator><creator>KAMBE, FUKUSHI</creator><creator>HAYASHI, YOSHITAKA</creator><creator>OHMORI, SACHIKO</creator><creator>FUNAHASHI, HIROOMI</creator><creator>SEO, HISAO</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>Involvement of AP-1 and Steroidogenic Factor (SF)-1 in the cAMP-Dependent Induction of Human Adrenocorticotropic Hormone Receptor (ACTHR) Promoter</title><author>SARKAR, DEVANAND ; KAMBE, FUKUSHI ; HAYASHI, YOSHITAKA ; OHMORI, SACHIKO ; FUNAHASHI, HIROOMI ; SEO, HISAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c621t-200cfd8b12649d5c9adc1d2a91734cd9085186ff9f00ee6326f0b6d5818622003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>ACTH receptor</topic><topic>Animals</topic><topic>AP-1</topic><topic>Base Sequence - genetics</topic><topic>Binding Sites</topic><topic>cAMP</topic><topic>Cell Line</topic><topic>COS Cells</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic AMP - physiology</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>DNA-Binding Proteins - physiology</topic><topic>Electrophoresis</topic><topic>Fushi Tarazu Transcription Factors</topic><topic>Gene Expression Regulation - physiology</topic><topic>Homeodomain Proteins</topic><topic>Humans</topic><topic>Molecular Sequence Data</topic><topic>Promoter</topic><topic>Promoter Regions, Genetic</topic><topic>Receptors, Corticotropin - genetics</topic><topic>Receptors, Cytoplasmic and Nuclear</topic><topic>SF-1</topic><topic>Steroidogenic Factor 1</topic><topic>Transcription Factor AP-1 - metabolism</topic><topic>Transcription Factor AP-1 - physiology</topic><topic>Transcription Factors - metabolism</topic><topic>Transcription Factors - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SARKAR, DEVANAND</creatorcontrib><creatorcontrib>KAMBE, FUKUSHI</creatorcontrib><creatorcontrib>HAYASHI, YOSHITAKA</creatorcontrib><creatorcontrib>OHMORI, SACHIKO</creatorcontrib><creatorcontrib>FUNAHASHI, HIROOMI</creatorcontrib><creatorcontrib>SEO, HISAO</creatorcontrib><creatorcontrib>Department of Endocrinology and Metabolism</creatorcontrib><creatorcontrib>Nagoya University School of Medicine</creatorcontrib><creatorcontrib>Research Institute of Environmental Medicine</creatorcontrib><creatorcontrib>nagoya University</creatorcontrib><creatorcontrib>Department of Surgery II</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ENDOCRINE JOURNAL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SARKAR, DEVANAND</au><au>KAMBE, FUKUSHI</au><au>HAYASHI, YOSHITAKA</au><au>OHMORI, SACHIKO</au><au>FUNAHASHI, HIROOMI</au><au>SEO, HISAO</au><aucorp>Department of Endocrinology and Metabolism</aucorp><aucorp>Nagoya University School of Medicine</aucorp><aucorp>Research Institute of Environmental Medicine</aucorp><aucorp>nagoya University</aucorp><aucorp>Department of Surgery II</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of AP-1 and Steroidogenic Factor (SF)-1 in the cAMP-Dependent Induction of Human Adrenocorticotropic Hormone Receptor (ACTHR) Promoter</atitle><jtitle>ENDOCRINE JOURNAL</jtitle><addtitle>Endocr J</addtitle><date>2000</date><risdate>2000</risdate><volume>47</volume><issue>1</issue><spage>63</spage><epage>75</epage><pages>63-75</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>Adrenocorticotropic hormone receptor (ACTHR) is expressed predominantly in the adrenal glands, and its expression is upregulated by its own ligand, ACTH, via a cAMP-dependent pathway. In the present study, we characterized the 5'-regulatory region of human ACTHR gene to elucidate the molecular mechanisms underlying its adrenal-specific and ACTH/cAMP-dependent expression. The promoter region (-1017/+47 when the transcription start site is regarded as +1) and its serial 5'-deletions (-764/+47, -503/+47, -214/+47 and -561+47) were ligated into the upstream of a luciferase (luc) reporter gene. These constructs were transfected into adrenocortical Y1 cells or non-adrenal JEG3 and Cos-1 cells. In all the cell lines, the luc activity gradually increased with serial 5'-deletions and the maximum activity was conferred by -56/+47. However, the magnitude of luc activity of each deletion construct in non-adrenal cells was much less than that in Y1 cells, suggesting that the promoter functions in an adrenal-specific manner. We identified two Steroidogenic Factor (SF)-1-binding sites at -209 and -35. Electrophoretic mobility shift assay (EMSA) demonstrated that both sites bind to SF-1. Mutation of both sites significantly decreased the activity of -214/+47 promoter in Y1 cells. Transfection of SF-1-expressing plasmid into non-adrenal cells significantly increased the promoter activity, suggesting that SF-1 plays a role in the tissue-specific expression of human ACTHR gene. We identified the region, -764 to -503, that was required for the for- skolin/camp responsiveness of the promoter. This region contains one AP-1 site. EMSA revealed that the binding of AP-1 to this site increased significantly upon treatment of Y1 cells with forskolin. Mutation of the site abolished the forskolin-responsiveness. In non-adrenal cells, the forskolin-responsiveness was observed only when SF-1-expressing plasmid was cotransfected. This is the first demonstration that both AP-1 and SF-1 are required for the cAMP-dependent induction of human ACTHR gene.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>10811295</pmid><doi>10.1507/endocrj.47.63</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-8959
ispartof Endocrine Journal, 2000, Vol.47(1), pp.63-75
issn 0918-8959
1348-4540
language eng
recordid cdi_proquest_miscellaneous_71141670
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects ACTH receptor
Animals
AP-1
Base Sequence - genetics
Binding Sites
cAMP
Cell Line
COS Cells
Cyclic AMP - metabolism
Cyclic AMP - physiology
DNA-Binding Proteins - metabolism
DNA-Binding Proteins - physiology
Electrophoresis
Fushi Tarazu Transcription Factors
Gene Expression Regulation - physiology
Homeodomain Proteins
Humans
Molecular Sequence Data
Promoter
Promoter Regions, Genetic
Receptors, Corticotropin - genetics
Receptors, Cytoplasmic and Nuclear
SF-1
Steroidogenic Factor 1
Transcription Factor AP-1 - metabolism
Transcription Factor AP-1 - physiology
Transcription Factors - metabolism
Transcription Factors - physiology
title Involvement of AP-1 and Steroidogenic Factor (SF)-1 in the cAMP-Dependent Induction of Human Adrenocorticotropic Hormone Receptor (ACTHR) Promoter
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A30%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20AP-1%20and%20Steroidogenic%20Factor%20(SF)-1%20in%20the%20cAMP-Dependent%20Induction%20of%20Human%20Adrenocorticotropic%20Hormone%20Receptor%20(ACTHR)%20Promoter&rft.jtitle=ENDOCRINE%20JOURNAL&rft.au=SARKAR,%20DEVANAND&rft.aucorp=Department%20of%20Endocrinology%20and%20Metabolism&rft.date=2000&rft.volume=47&rft.issue=1&rft.spage=63&rft.epage=75&rft.pages=63-75&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.47.63&rft_dat=%3Cproquest_cross%3E71141670%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71141670&rft_id=info:pmid/10811295&rfr_iscdi=true